{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T18:14:59Z","timestamp":1784916899013,"version":"3.55.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>G protein\u2013coupled receptors can signal through both G proteins and <jats:italic>\u00df<\/jats:italic>-arrestin2. For the <jats:italic>\u00b5<\/jats:italic>-opioid receptor (MOR), early experimental evidence from a single study suggested that G protein signaling mediates analgesia and sedation, whereas <jats:italic>\u00df<\/jats:italic>-arrestin signaling mediates respiratory depression and constipation. Then, receptor mutations were used to clarify which residues interact with ligands to selectively regulate signals in a ligand-specific manner. However, there is no systematic study on how to determine these residues and clarify the molecular mechanism of their influence on signal pathways. We have therefore used molecular docking to predict the amino acid sites that affect the binding of ligands and MOR. Then, the corresponding sites were mutated to determine the effect of the structural determinant of MOR on G<jats:sub>i\/o<\/jats:sub> protein and <jats:italic>\u00df<\/jats:italic>-arrestin pathways. The pharmacological and animal behavioral experiments in combination with molecular dynamics simulations were used to elucidate the molecular mechanism of key residues governing the signaling. Without affecting ligand binding to MOR, MOR<jats:sup>Y7.43A<\/jats:sup> attenuated the activation of both G<jats:sub>i\/o<\/jats:sub> protein and <jats:italic>\u00df<\/jats:italic>-arrestin signaling pathways stimulated by fentanyl, whereas it did not change these two pathways stimulated by morphine. Likewise, the activation peak time of extracellular regulated protein kinases was significantly prolonged at MOR<jats:sup>Y7.43A<\/jats:sup> compared with that at MOR<jats:sup>wildtype<\/jats:sup> stimulated by fentanyl, but there was no difference stimulated by morphine. In addition, MOR<jats:sup>Y7.43A<\/jats:sup> significantly enhanced analgesia by fentanyl but not by morphine in the mice behavioral experiment. Furthermore, the molecular dynamics simulations showed that H6 moves toward the cellular membrane. H6 of the fentanyl\u2013Y7.43A system moved outward more than that in the morphine\u2013Y7.43A system. Y7.43 mutation disrupted hydrophobic interactions between W6.48 and Y7.43 in the fentanyl\u2013Y7.43A system but not in the morphine\u2013Y7.43A system. Our results have disclosed novel mechanisms of Y7.43 mutation affecting MOR signaling pathways. Y7.43 mutation reduced the activation of the G<jats:sub>i\/o<\/jats:sub> protein pathway and blocked the <jats:italic>\u00df<\/jats:italic>-arrestin2 recruitment, increased the H6 outward movement of MOR, and disrupted hydrophobic interactions. This may be responsible for the enhanced fentanyl analgesia. These findings are conducive to designing new drugs from the perspective of ligand and receptor binding, and Y7.43 is also expected to be a key site to structure optimization of synthesized compounds.<\/jats:p>","DOI":"10.3389\/fphar.2022.919325","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T09:11:41Z","timestamp":1662109901000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Tyrosine 7.43 is important for mu-opioid receptor downstream signaling pathways activated by fentanyl"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiangyun","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruibin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"key":"B1","first-page":"890","article-title":"The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H(2) receptor","volume":"57","author":"Alewijnse","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e62552","DOI":"10.7554\/eLife.62552","article-title":"\u00df-arrestin 2 germline knockout does not attenuate opioid respiratory depression","volume":"10","author":"Bachmutsky","year":"2021","journal-title":"Elife"},{"key":"B3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1098\/rspb.1983.0093","article-title":"Operational models of pharmacological agonism","volume":"220","author":"Black","year":"1983","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/ncomms2028","article-title":"The allosteric vestibule of a seven transmembrane helical receptor controls G-protein coupling","volume":"3","author":"Bock","year":"2012","journal-title":"Nat. Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3109\/00207454.2014.896913","article-title":"Enhancement of morphine analgesia and prevention of morphine tolerance by downregulation of beta-arrestin 2 with antigene RNAs in mice","volume":"125","author":"Bu","year":"2015","journal-title":"Int. J. Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2011.10.006","article-title":"Drug discovery targeting human 5-HT(2C) receptors: residues S3.36 and Y7.43 impact ligand-binding pocket structure via hydrogen bond formation","volume":"673","author":"Canal","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"8019","DOI":"10.1021\/jm4010829","article-title":"Structure-activity relationships and discovery of a G protein biased mu opioid receptor ligand, [(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan- 9-yl]ethyl})amine (TRV130), for the treatment of acute severe pain","volume":"56","author":"Chen","year":"2013","journal-title":"J. Med. Chem."},{"key":"B8","first-page":"8","article-title":"Molecular cloning and functional expression of a mu-opioid receptor from rat brain","volume":"44","author":"Chen","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/aps.2017.158","article-title":"Computational insights into the G-protein-biased activation and inactivation mechanisms of the mu opioid receptor","volume":"39","author":"Cheng","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"B10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0304-3959(93)90161-H","article-title":"Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence","volume":"52","author":"Coderre","year":"1993","journal-title":"Pain"},{"key":"B11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1742-2094-2-15","article-title":"Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human beta-amyloid","volume":"2","author":"Craft","year":"2005","journal-title":"J. Neuroinflammation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1039\/d1md00041a","article-title":"Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors","volume":"12","author":"De Neve","year":"2021","journal-title":"RSC Med. Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1007394","DOI":"10.1371\/journal.pcbi.1007394","article-title":"Molecular mechanisms of fentanyl mediated beta-arrestin biased signaling","volume":"16","author":"de Waal","year":"2020","journal-title":"PLoS Comput. Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1124\/jpet.112.201616","article-title":"A G protein-biased ligand at the mu-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine","volume":"344","author":"DeWire","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.peptides.2019.01.003","article-title":"Inflammatory mediators of opioid tolerance: implications for dependency and addiction","volume":"115","author":"Eidson","year":"2019","journal-title":"Peptides"},{"key":"B16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature12944","article-title":"Molecular control of delta-opioid receptor signalling","volume":"506","author":"Fenalti","year":"2014","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1124\/mol.111.075457","article-title":"Receptor conformations involved in dopamine D(2L) receptor functional selectivity induced by selected transmembrane-5 serine mutations","volume":"81","author":"Fowler","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1056\/NEJMp1615145","article-title":"Addressing the fentanyl threat to public health","volume":"376","author":"Frank","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.3390\/molecules25112473","article-title":"On the role of peripheral sensory and gut mu opioid receptors: Peripheral analgesia and tolerance","volume":"25","author":"Furst","year":"2020","journal-title":"Molecules"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1124\/mol.106.026716","article-title":"Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy","volume":"70","author":"Galandrin","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.bcp.2015.09.010","article-title":"Forskolin-free cAMP assay for Gi-coupled receptors","volume":"98","author":"Gilissen","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"eaaz3140","DOI":"10.1126\/scisignal.aaz3140","article-title":"Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists","volume":"13","author":"Gillis","year":"2020","journal-title":"Sci. Signal."},{"key":"B23","article-title":"Anesthetic and analgesic drug products advisory committee (AADPAC)","author":"Hertz","year":"2018"},{"key":"B24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.neuropharm.2017.03.007","article-title":"Residues W320 and Y328 within the binding site of the mu-opioid receptor influence opiate ligand bias","volume":"118","author":"Hothersall","year":"2017","journal-title":"Neuropharmacology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1021\/acschemneuro.0c00487","article-title":"Design, synthesis, and structure-activity relationship exploration of alkyl\/phenylalkyl piperidine analogues as novel highly potent and selective mu opioid receptor agonists","volume":"12","author":"Huang","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature14886","article-title":"Structural insights into \u00b5-opioid receptor activation","volume":"524","author":"Huang","year":"2015","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/cpdd.721","article-title":"A first-in-human clinical study with TRV734, an orally bioavailable G-protein-biased ligand at the mu-opioid receptor","volume":"9","author":"James","year":"2020","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0922-4106(95)90036-5","article-title":"The function of a highly-conserved arginine residue in activation of the muscarinic M1 receptor","volume":"288","author":"Jones","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1111\/bph.12222","article-title":"Efficacy and ligand bias at the mu-opioid receptor","volume":"169","author":"Kelly","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nrd3954-c2","article-title":"Measurements of ligand bias and functional affinity","volume":"12","author":"Kenakin","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"B31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1124\/jpet.110.173948","article-title":"Functional selectivity and biased receptor signaling","volume":"336","author":"Kenakin","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1021\/cn200111m","article-title":"A simple method for quantifying functional selectivity and agonist bias","volume":"3","author":"Kenakin","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"12048","DOI":"10.1073\/pnas.89.24.12048","article-title":"The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization","volume":"89","author":"Kieffer","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1111\/bph.15004","article-title":"Morphine-induced respiratory depression is independent of beta-arrestin2 signalling","volume":"177","author":"Kliewer","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41467-018-08162-1","article-title":"Phosphorylation-deficient G-protein-biased mu-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects","volume":"10","author":"Kliewer","year":"2019","journal-title":"Nat. Commun."},{"key":"B36","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.omtm.2021.10.001","article-title":"Transgene distribution and immune response after ultrasound delivery of rAAV9 and PHP.B to the brain in a mouse model of amyloidosis","volume":"23","author":"Kofoed","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B37","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1523\/jneurosci.02-06-00765.1982","article-title":"Peripheral neural mechanisms of cutaneous hyperalgesia following mild injury by heat","volume":"2","author":"LaMotte","year":"1982","journal-title":"J. Neurosci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.4097\/kjae.2014.67.5.299","article-title":"Opioid induced hyperalgesia in anesthetic settings","volume":"67","author":"Lee","year":"2014","journal-title":"Korean J. Anesthesiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1124\/mol.51.2.234","article-title":"The role of the aspartate-arginine-tyrosine triad in the m1 muscarinic receptor: mutations of aspartate 122 and tyrosine 124 decrease receptor expression but do not abolish signaling","volume":"51","author":"Lu","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1242\/jcs.115.3.455","article-title":"The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals","volume":"115","author":"Luttrell","year":"2002","journal-title":"J. Cell Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature10954","article-title":"Crystal structure of the \u00b5-opioid receptor bound to a morphinan antagonist","volume":"485","author":"Manglik","year":"2012","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1021\/jm000381r","article-title":"Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the \"address\" recognition locus","volume":"44","author":"Metzger","year":"2001","journal-title":"J. Med. Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1006\/bbrc.2002.6670","article-title":"Role of the conserved DRY motif on G protein activation of rat angiotensin II receptor type 1A","volume":"292","author":"Ohyama","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1124\/pr.112.007138","article-title":"Mu opioids and their receptors: evolution of a concept","volume":"65","author":"Pasternak","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e66009","DOI":"10.1371\/journal.pone.0066009","article-title":"A computationally designed water-soluble variant of a G-protein-coupled receptor: the human mu opioid receptor","volume":"8","author":"Perez-Aguilar","year":"2013","journal-title":"PLoS One"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1124\/pr.111.004598","article-title":"Functional selectivity at the mu-opioid receptor: implications for understanding opioid analgesia and tolerance","volume":"63","author":"Raehal","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1124\/jpet.105.087254","article-title":"Morphine side effects in beta-arrestin 2 knockout mice","volume":"314","author":"Raehal","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B49","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.bmcl.2015.12.024","article-title":"Biased agonism: an emerging paradigm in GPCR drug discovery","volume":"26","author":"Rankovic","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B50","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1124\/mol.56.1.175","article-title":"Mutation of a highly conserved aspartic acid in the beta2 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6","volume":"56","author":"Rasmussen","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41434-018-0005-z","article-title":"Widespread transduction of astrocytes and neurons in the mouse central nervous system after systemic delivery of a self-complementary AAV-PHP.B vector","volume":"25","author":"Rincon","year":"2018","journal-title":"Gene Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1096\/fj.06-7793com","article-title":"Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers","volume":"21","author":"Rozenfeld","year":"2007","journal-title":"FASEB J."},{"key":"B53","doi-asserted-by":"publisher","first-page":"15045","DOI":"10.1002\/jcb.28766","article-title":"Activation of spinal Extacellular Signal-Regulated Kinases and c-jun N-terminal kinase signaling pathways contributes to morphine-induced acute and chronic hyperalgesia in mice","volume":"120","author":"Ruan","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"B54","first-page":"219","article-title":"Mutational analysis of the highly conserved arginine within the glu\/asp-arg-tyr motif of the alpha(1b)-adrenergic receptor: effects on receptor isomerization and activation","volume":"57","author":"Scheer","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.cell.2017.10.035","article-title":"Bias factor and therapeutic window correlate to predict safer opioid analgesics","volume":"171","author":"Schmid","year":"2017","journal-title":"Cell"},{"key":"B56","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1124\/jpet.109.163220","article-title":"Impact of the DRY motif and the missing \"ionic lock\" on constitutive activity and G-protein coupling of the human histamine H4 receptor","volume":"333","author":"Schneider","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B57","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.bbrc.2020.05.073","article-title":"A20 enhances mu-opioid receptor function by inhibiting beta-arrestin2 recruitment","volume":"528","author":"Shao","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B58","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/jcph.207","article-title":"First clinical experience with TRV130: pharmacokinetics and pharmacodynamics in healthy volunteers","volume":"54","author":"Soergel","year":"2014","journal-title":"J. Clin. Pharmacol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-med-062613-093100","article-title":"Opioid receptors","volume":"67","author":"Stein","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1021\/jm9903702","article-title":"Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor","volume":"43","author":"Subramanian","year":"2000","journal-title":"J. Med. Chem."},{"key":"B61","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1002\/chem.201605575","article-title":"Propagation of the allosteric modulation induced by sodium in the delta-opioid receptor","volume":"23","author":"Sun","year":"2017","journal-title":"Chemistry"},{"key":"B62","doi-asserted-by":"publisher","first-page":"969","DOI":"10.2147\/JPR.S278279","article-title":"Oliceridine: A novel drug for the management of moderate to severe acute pain - a review of current evidence","volume":"14","author":"Tan","year":"2021","journal-title":"J. Pain Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1124\/mol.110.068106","article-title":"Histidine 6.55 is a major determinant of ligand-biased signaling in dopamine D2L receptor","volume":"79","author":"Tschammer","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cell.2017.07.009","article-title":"How ligands illuminate GPCR molecular pharmacology","volume":"170","author":"Wacker","year":"2017","journal-title":"Cell"},{"key":"B65","doi-asserted-by":"publisher","first-page":"19351","DOI":"10.1074\/jbc.M114.558882","article-title":"Tyrosine 308 is necessary for ligand-directed Gs protein-biased signaling of \u03b22-adrenoceptor","volume":"289","author":"Woo","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B66","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1124\/mol.115.101246","article-title":"A hydrogen-bonded polar network in the core of the glucagon-like peptide-1 receptor is a fulcrum for biased agonism: lessons from class B crystal structures","volume":"89","author":"Wootten","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"117676","DOI":"10.1016\/j.lfs.2020.117676","article-title":"Hsp90\u03b2 positively regulates \u03bc-opioid receptor function","volume":"252","author":"Zhang","year":"2020","journal-title":"Life Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.919325\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T09:11:46Z","timestamp":1662109906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.919325\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":67,"alternative-id":["10.3389\/fphar.2022.919325"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.919325","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"article-number":"919325"}}